NRSN – neurosense therapeutics ltd. (US:NASDAQ)

News

NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition
NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease
World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB [Yahoo! Finance]
World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB
NeuroSense Therapeutics (NASDAQ:NRSN) was upgraded by analysts at Wall S
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com